Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

More exercise might link to hair loss, but other factors also matter.

Stopping heptaminol medication reversed hair color loss in a patient on dialysis.

Spironolactone may help reduce hair loss in androgenic alopecia.

Two major dermatology conferences were held in 2006, focusing on skin immunity and various skin diseases.

Low zinc levels in chronic liver disease patients are linked to more severe symptoms like taste issues and skin problems, and zinc supplements might help.

Biotin supplements increased biotin levels but did not significantly prevent hair loss in rats on valproic acid.

COVID-19 infection may trigger alopecia areata in some patients.

POUF51 and HES3 are key in controlling stem cell numbers in psoriasis.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Lupus can cause hair loss and nail changes, with treatments available for both.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Psoriasis is the most common cause of erythroderma, and proper medical follow-up is crucial.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Biotin supplements are unnecessary for most people but may help with certain conditions like biotin deficiency, brittle nails, and some hair loss.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Lower irisin levels in the blood may indicate more severe acne.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Crohn's disease can cause hair loss before other symptoms appear.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

Juvenile dermatomyositis can worsen quickly and needs strong treatment.